室下区
神经干细胞
胶质母细胞瘤
组织蛋白酶D
生物
癌症研究
蛋白质组学
恶性肿瘤
计算生物学
细胞生物学
干细胞
基因
生物化学
遗传学
酶
作者
Emily S. Norton,Lauren Whaley,Vanessa K. Jones,Mieu Brooks,Marissa Russo,Dmytro Morderer,Erik Jessen,Paula Schiapparelli,Andres Ramos‐Fresnedo,Natanael Zarco,Anna Carrano,Wilfried Rossoll,Yan W. Asmann,TuKiet T. Lam,Kaisorn L. Chaichana,Panos Z. Anastasiadis,Alfredo Quiñones‐Hinojosa,Hugo Guerrero-Cázares
出处
期刊:Science Advances
[American Association for the Advancement of Science]
日期:2024-08-07
卷期号:10 (32)
被引量:6
标识
DOI:10.1126/sciadv.adn1607
摘要
Glioblastoma (GBM) is the most prevalent and aggressive malignant primary brain tumor. GBM proximal to the lateral ventricles (LVs) is more aggressive, potentially because of subventricular zone contact. Despite this, cross-talk between GBM and neural stem/progenitor cells (NSC/NPCs) is not well understood. Using cell-specific proteomics, we show that LV-proximal GBM prevents neuronal maturation of NSCs through induction of senescence. In addition, GBM brain tumor-initiating cells (BTICs) increase expression of cathepsin B (CTSB) upon interaction with NPCs. Lentiviral knockdown and recombinant protein experiments reveal that both cell-intrinsic and soluble CTSB promote malignancy-associated phenotypes in BTICs. Soluble CTSB stalls neuronal maturation in NPCs while promoting senescence, providing a link between LV-tumor proximity and neurogenesis disruption. Last, we show LV-proximal CTSB up-regulation in patients, showing the relevance of this cross-talk in human GBM biology. These results demonstrate the value of proteomic analysis in tumor microenvironment research and provide direction for new therapeutic strategies in GBM.
科研通智能强力驱动
Strongly Powered by AbleSci AI